![]() |
Volumn 21, Issue 5, 2002, Pages 393-399
|
Defining the potential impact of conjugate bacterial polysaccharide-protein vaccines in reducing the burden of pneumonia in human immunodeficiency virus type 1-infected and -uninfected children
a
|
Author keywords
Bacteria; Chest radiograph; Conjugate vaccine; Human immunodeficiency virus; Pneumonia; Respiratory virus
|
Indexed keywords
BACTERIAL POLYSACCHARIDE;
BACTERIAL VACCINE;
FLUORESCEIN;
BACTERIAL PROTEIN;
PNEUMOCOCCUS VACCINE;
VACCINE;
ARTICLE;
BACTEREMIA;
BACTERIAL PNEUMONIA;
BLOOD CULTURE;
CHILD;
DRUG EFFICACY;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOASSAY;
INFANT;
LOWER RESPIRATORY TRACT INFECTION;
MAJOR CLINICAL STUDY;
MALE;
PNEUMONIA;
PREVALENCE;
PRIORITY JOURNAL;
STREPTOCOCCUS PNEUMONIA;
THORAX RADIOGRAPHY;
VIRUS PNEUMONIA;
BIOASSAY;
COST OF ILLNESS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IMMUNOLOGY;
LUNG ALVEOLUS;
MICROBIOLOGY;
PATHOGENICITY;
PATHOLOGY;
PNEUMOCYSTIS PNEUMONIA;
PRESCHOOL CHILD;
RADIOGRAPHY;
STREPTOCOCCUS INFECTION;
TREATMENT OUTCOME;
BACTERIAL PROTEINS;
CHILD, PRESCHOOL;
COST OF ILLNESS;
ENDPOINT DETERMINATION;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
INFANT;
MALE;
PNEUMOCOCCAL INFECTIONS;
PNEUMOCOCCAL VACCINES;
PNEUMONIA;
PNEUMONIA, PNEUMOCYSTIS;
PULMONARY ALVEOLI;
RADIOGRAPHY, THORACIC;
TREATMENT OUTCOME;
VACCINES, CONJUGATE;
|
EID: 0035999344
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/00006454-200205000-00009 Document Type: Article |
Times cited : (14)
|
References (22)
|